The management of neck metastases in nasopharyngeal cancer

Current Opinion in Otolaryngology and Head and Neck Surgery

Volumn 15, Issue 2, 2007, Pages 99-102

  Wei, William I ^a   Mok, Vivian W K ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Cancer; Metastases; Nasopharyngeal; Neck

Indexed keywords

BRACHYTHERAPY; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; HUMAN; LYMPH NODE; LYMPH NODE METASTASIS; MINIMAL RESIDUAL DISEASE; MULTIMODALITY CANCER THERAPY; NASOPHARYNX CANCER; NECK METASTASIS; NEEDLE BIOPSY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RECURRENT CANCER; REVIEW; SALVAGE THERAPY; TREATMENT PLANNING;

HUMANS; LYMPHATIC METASTASIS; NASOPHARYNGEAL NEOPLASMS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM, RESIDUAL;

EID: 34247126476     PISSN: 10689508     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOO.0b013e3280148a06     Document Type: Review

References (30)

1. Lee AW, Foo W, Law SC, et al. Nasopharyngeal carcinoma: presenting symptoms and duration before diagnosis. Hong Kong Med J 1997; 3:355-361.
2. Kollur SM, El Hag IA. Fine-needle aspiration cytology of metastatic nasopharyngeal carcinoma in cervical lymph nodes: comparison with metastatic squamous-cell carcinoma, and Hodgkin's and non-Hodgkin's lymphoma. Diagn Cytopathol 2003; 28:18-22.
3. Liu LZ, Zhang GY, Xie CM, et al. Magnetic resonance imaging of retropharyngeal lymph node metastasis in nasopharyngeal carcinoma: patterns of spread. Int J Radiat Oncol Biol Phys 2006; 66:721-730. The authors describe the pattern of lymph node metastasis in nasopharyngeal carcinoma.
4. Wakisaka M, Mori H, Fuwa N, Matsumoto A. MR analysis of nasopharyngeal carcinoma: correlation of the pattern of tumor extent at the primary site with the distribution of metastasized cervical lymph nodes. Preliminary results. Eur Radiol 2000; 10:970-977.
5. Tai CJ, Liu FY, Liang JA, et al. Detection of cervical lymph node metastases in nasopharyngeal carcinomas: comparison with technetium-99m tetrofosmin single photon emission computed tomography and with magnetic resonance imaging. Anticancer Res 2003; 23:719-722.
6. Kao CH, Hsieh JF, Tsai SC, et al. Comparison of 18-fluoro-2-deoxyglucose positron emission tomography and computed tomography in detection of cervical lymph node metastases of nasopharyngeal carcinoma. Ann Otol Rhinol Laryngol 2000; 109:1130-1134.
7. Yen TC, Chang YC, Chan SC, et al. Are dual-phase 18F-FDG PET scans necessary in nasopharyngeal carcinoma to assess the primary tumour and loco-regional nodes? Eur J Nucl Med Mol Imaging 2005; 32:541-548.
8. Chen YK, Su CT, Ding HJ, et al. Clinical usefulness of fused PET/CT compared with PET alone or CT alone in nasopharyngeal carcinoma patients. Anticancer Res 2006; 26:1471-1477. The efficacy of fused PET/CT in the evaluation of disease in nasopharyngeal carcinoma is described.
9. Cooper JS, Cohen R, Stevens RE. A comparision of staging systems for nasopharyngeal carcinoma. Cancer 1998; 83:213-219.
10. Özyar E, Yildiz F, Akyol FH, Atahan II. Comparison of AJCC 1988 and 1997 classifications for nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 1999; 44:1079-1087.
11. Wei WI, Sham JS. Nasopharyngeal carcinoma. Lancet 2005; 365:2041-2054; Review. This is a review article on the current status of management of nasopharyngeal carcinoma, covering all aspects.
12. Lee AW, Sham JS, Poon YF, Ho JH. Treatment of stage I nasopharyngeal carcinoma: analysis of the patterns of relapse and the results of withholding elective neck irradiation. Int J Radiat Oncol Biol Phys 1989; 17:1183-1190.
13. Chua DT, Sham JS, Wei WI, et al. The predictive value of the 1997 American Joint Committee on Cancer stage classification in determining failure patterns in nasopharyngeal carcinoma. Cancer 2001; 92:2845-2855.
14. Wu VW, Kwong DL, Sham JS. Target dose conformity in 3-dimensional conformal radiotherapy and intensity modulated radiotherapy. Radiother Oncol 2004; 71:201-206.
15. Hsiung CY, Yorke ED, Chui CS, et al. Intensity-modulated radiotherapy versus conventional three-dimensional conformal radiotherapy for boost or salvage treatment of nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 2002; 53:638-647.
16. Kam MK, Chau RM, Suen J, et al. Intensity-modulated radiotherapy in nasopharyngeal carcinoma: dosimetric advantage over conventional plans and feasibility of dose escalation. Int J Radiat Oncol Biol Phys 2003; 56:145-157.
17. Al-Sarraf M, LeBlanc M, Giri PG, et al. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: Phase III randomized Intergroup Study 0099. J Clin Oncol 1998; 16:1310-1317.
18. Chua DT, Sham JS, Au GK, Choy D. Concomitant chemoirradiation for stage III-IV nasopharyngeal carcinoma in Chinese patients: results of a matched cohort analysis. Int J Radiat Oncol Biol Phys 2002; 53:334-343.
19. Lee AW, Lau WH, Tung SY, et al. Hong Kong Nasopharyngeal Cancer Study Group. Preliminary results of a randomized study on therapeutic gain by concurrent chemotherapy for regionally-advanced nasopharyngeal carcinoma: NPC-9901 Trial by the Hong Kong Nasopharyngeal Cancer Study Group. J Clin Oncol 2005; 23:6966-6975. This presents the results of a randomized trial showing the efficacy of concomitant chemotherapy and radiotherapy.
20. Samant S, Kumar P, Wan J, et al. Concomitant radiation therapy and targeted cisplatin chemotherapy for the treatment of advanced pyriform sinus carcinoma: disease control and preservation of organ function. Head Neck 1999; 21:595-601.
21. Huang SC, Lui LT, Lynn TC. Nasopharyngeal cancer: study III. A review of 1206 patients treated with combined modalities. Int J Radiat Oncol Biol Phys 1985; 11:1789-1793.
22. Liu MT, Hsieh CY, Chang TH, et al. Prognostic factors affecting the outcome of nasopharyngeal carcinoma. Jpn J Clin Oncol 2003; 33:501-508.
23. Palazzi M, Guzzo M, Bossi P, et al. Regionally advanced nasopharyngeal carcinoma: long-term outcome after sequential chemotherapy and radiotherapy. Tumori 2004; 90:60-65.
24. Ahuja A, Ying M, Yuen YH, Metreweli C. Power Doppler sonography to differentiate tuberculous cervical lymphadenopathy from nasopharyngeal carcinoma. AJNR Am J Neuroradiol 2001; 22:735-740.
25. Yen RF, Hong RL, Tzen KY, et al. Whole-body 18F-FDG PET in recurrent or metastatic nasopharyngeal carcinoma. J Nucl Med 2005; 46:770-774. The authors describe the application of PET in the detection of recurrent nasopharyngeal carcinoma.
26. Sham JS, Choy D. Nasopharyngeal carcinoma: treatment of neck node recurrence by radiotherapy. Australas Radiol 1991; 35:370-373.
27. Pletcher SD, Kaplan MJ, Eisele DW, et al.Management of cervical metastases in advanced squamous cell carcinoma of the base of tongue. Arch Otolaryngol Head Neck Surg 2003; 129:983-986.
28. Wei WI, Lam KH, Ho CM, et al. Efficacy of radical neck dissection for the control of cervical metastasis after radiotherapy for nasopharyngeal carcinoma. Am J Surg 1990; 160:439-442.
29. Wei WI, Ho CM, Wong MP, et al. Pathological basis of surgery in the management of postradiotherapy cervical metastasis in nasopharyngeal carcinoma. Arch Otolaryngol Head Neck Surg 1992; 118:923-929.
30. Wei WI, Ho WK, Cheng AC, et al. Management of extensive cervical nodal metastasis in nasopharyngeal carcinoma after radiotherapy: a clinicopathological study. Arch Otolaryngol Head Neck Surg 2001; 127:1457-1462.